Innovative Eyewear (LUCY) Net Income towards Common Stockholders (2021 - 2025)
Innovative Eyewear (LUCY) reported Net Income towards Common Stockholders of -$2.7 million for Q4 2025, down 23.65% on a YoY basis from -$3.6 million in Q4 2024, and up 82.53% sequentially from -$15.5 million in Q3 2025.
Innovative Eyewear (LUCY) Net Income towards Common Stockholders (2021 - 2025) Analysis & Trends
Innovative Eyewear (LUCY) has 5 years of Net Income towards Common Stockholders data on file, last reported at -$2.7 million in Q4 2025.
- For the quarter ending Q4 2025, Net Income towards Common Stockholders fell 23.65% year-over-year to -$2.7 million; the trailing twelve-month figure through Dec 2025 stood at -$37.2 million (down 233.72% YoY), and the FY2025 full-year result was -$10.0 million, down 22.51% from the prior year.
- Net Income towards Common Stockholders improved to -$2.7 million in Q4 2025, from -$15.5 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of -$532763.0 in Q2 2021 to a low of -$15.5 million in Q1 2025.
- A 5-year average of -$4.1 million and a median of -$2.2 million in 2024 frame the typical range for Net Income towards Common Stockholders.
- Across the five-year window, Net Income towards Common Stockholders plunged 959.29% in 2023 and jumped 77.77% in 2024, its largest moves.
- Tracing LUCY's Net Income towards Common Stockholders over 5 years: stood at -$1.4 million in 2021, then plunged by 35.73% to -$1.9 million in 2022, then sank by 32.71% to -$2.5 million in 2023, then climbed by 12.15% to -$2.2 million in 2024, then decreased by 23.65% to -$2.7 million in 2025.
- Business Quant data shows LUCY's Net Income towards Common Stockholders at -$2.7 million in Q4 2025, -$15.5 million in Q3 2025, and -$3.5 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.72 Bn | 121.51 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 44.88 Bn | 44.07 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Alcon | 33.19 Bn | 31.53 Bn | 1.53 Bn | 22.13 Bn |
| 4 | Medline | 32.91 Bn | 30.67 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 29.46 Bn | 27.80 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 23.22 Bn | 22.79 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 14.06 Bn | 13.50 Bn | 1.10 Bn | 13.00 Mn |
| 8 | Cooper Companies | 13.85 Bn | 13.71 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Align Technology | 12.13 Bn | 11.07 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Innovative Eyewear | 2.86 Mn | -4.92 Mn | 114,746.00 | -2.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.71 Mn |
| Sep 30, 2025 | -15.51 Mn |
| Jun 30, 2025 | -3.46 Mn |
| Mar 31, 2025 | -15.54 Mn |
| Dec 31, 2024 | -2.19 Mn |
| Sep 30, 2024 | -3.31 Mn |
| Jun 30, 2024 | -2.81 Mn |
| Mar 31, 2024 | -2.85 Mn |
| Dec 31, 2023 | -2.50 Mn |
| Sep 30, 2023 | -14.87 Mn |
| Jun 30, 2023 | -1.77 Mn |
| Mar 31, 2023 | -1.43 Mn |
| Dec 31, 2022 | -1.88 Mn |
| Sep 30, 2022 | -1.40 Mn |
| Jun 30, 2022 | -1.19 Mn |
| Mar 31, 2022 | -1.21 Mn |
| Dec 31, 2021 | -1.39 Mn |
| Sep 30, 2021 | -1.10 Mn |
| Jun 30, 2021 | -532,763.00 |